+971 56 274 1787WhatsApp
Skin, Hair & Nails

Hair Loss & Alopecia

Comprehensive integrative medicine approach for lasting healing and complete recovery

15,000+ Patients
DHA Licensed
Root Cause Focus
95% Success Rate

Understanding Hair Loss & Alopecia

Hair loss, medically termed alopecia, refers to excessive shedding or thinning of hair from the scalp or body. It encompasses several types including androgenetic alopecia (pattern hair loss), alopecia areata (autoimmune patchy loss), and telogen effluvium (stress-induced shedding), affecting both men and women. The condition results from disrupted hair follicle cycling, hormonal factors like dihydrotestosterone (DHT), autoimmune attacks, or nutritional deficiencies, impacting self-esteem and psychological well-being.

Key Symptoms

Recognizing Hair Loss & Alopecia

Common symptoms and warning signs to look for

Progressive thinning at the crown or temples (male/female pattern hair loss)

Sudden appearance of round, smooth bald patches on the scalp, beard, or eyebrows

Excessive daily shedding - finding clumps of hair on pillows, in the shower, or on brushes

Hair becoming noticeably finer, shorter, and less dense over time

Complete loss of body hair (alopecia universalis) in severe autoimmune cases

What a Healthy System Looks Like

In a healthy individual, hair follicles undergo a continuous cyclic process: the anagen (growth) phase lasting 2-7 years where hair grows approximately 1 cm per month, followed by the catagen (transitional) phase lasting 2-3 weeks, and finally the telogen (resting) phase lasting 2-4 months. At any given time, 85-90% of scalp hairs are in anagen phase, 10-15% in telogen, with less than 1% in catagen. Each follicle produces 20-30 lifetime cycles, with terminal hairs transforming to vellus hairs over time. The hair bulb receives nutrients through the dermal papilla, a structure rich in blood vessels and mesenchymal cells that regulate hair growth through growth factors, hormones, and cytokines. Sebaceous glands lubricate the hair shaft, maintaining luster and flexibility. Normal daily hair loss ranges from 50-100 hairs, which are naturally replaced by new anagen hairs.

Mechanism

How the Condition Develops

Understanding the biological mechanisms

1

Hair loss involves multiple pathophysiological mechanisms depending on type: (1) Androgenetic Alopecia - DHT (dihydrotestosterone) binds to androgen receptors in susceptible follicles, miniaturizing them over time; 5-alpha-reductase converts testosterone to DHT; follicles progressively shrink from terminal to vellus hairs; follicular lifespan shortens from years to months; (2) Alopecia Areata - CD8+ NKG2D+ T-cells attack hair bulb epithelial cells; perifollicular lymphocytic infiltrates (swarm of bees pattern); loss of immune privilege of the follicle; elevated IL-15 and IFN-gamma drive autoimmunity; may progress to alopecia totalis/universalis; (3) Telogen Effluvium - Premature synchronization of follicles into telogen phase; triggers include stress, fever, surgery, childbirth, medications; massive shedding 2-4 months after trigger; follicles remain viable but temporarily dormant; (4) Anagen Effluvium - Acute toxicity to rapidly dividing keratinocytes during anagen; common with chemotherapy; (5) Traction Alopecia - Mechanical pulling on hair (tight hairstyles); follicular inflammation and scarring from chronic tension.

Lab Values

Key Laboratory Markers

Important values for diagnosis and monitoring

TestNormal RangeOptimalSignificance
Ferritin (Iron Storage)30-200 ng/mL70-100 ng/mLIron storage protein; ferritin <30 ng/mL correlates with telogen effluvium; optimal levels >70 ng/mL needed for robust hair growth; deficiency common in women with heavy menstrual bleeding
Vitamin D3 (25-OH)30-100 ng/mL50-80 ng/mLVitamin D receptor expressed in hair follicles; deficiency associated with alopecia areata; modulates immune function and keratinocyte differentiation
Zinc (Serum)60-120 mcg/dL90-110 mcg/dLEssential for hair follicle proliferation; zinc deficiency causes telogen effluvium; required for DNA synthesis and cell division
TSH (Thyroid-Stimulating Hormone)0.4-4.0 mIU/L1.0-2.0 mIU/LThyroid dysfunction (both hypo and hyper) causes telogen effluvium; Hashimoto's thyroiditis common comorbidity with alopecia areata
Free T4 (Free Thyroxine)0.8-1.8 ng/dL1.2-1.5 ng/dLThyroid hormone deficiency leads to dry, brittle hair; excess causes fine, thinning hair
Free T3 (Free Triiodothyronine)2.3-4.2 pg/mL3.0-3.5 pg/mLActive thyroid hormone; low levels indicate conversion issues affecting hair quality
Testosterone (Total)300-1000 ng/dL (M), 15-70 ng/dL (F)400-700 ng/dL (M), 20-50 ng/dL (F)Baseline androgen levels; elevated in PCOS; converted to DHT by 5-alpha-reductase
DHT (Dihydrotestosterone)30-85 pg/mL<50 pg/mLPrimary androgen responsible for pattern hair loss; elevated in androgenetic alopecia; finasteride and dutasteride block its production
Hemoglobin12-16 g/dL (F), 14-18 g/dL (M)14-16 g/dL (F), 15-17 g/dL (M)Anemia causes telogen effluvium through reduced oxygen delivery to hair follicles; iron deficiency without anemia still affects hair
Vitamin B12200-900 pg/mL500-800 pg/mLEssential for DNA synthesis and cell division; deficiency causes premature graying and telogen effluvium
CRP (C-Reactive Protein)<3 mg/L<1 mg/LSystemic inflammation marker; elevated in active alopecia areata; chronic inflammation accelerates pattern hair loss
Morning Cortisol5-25 mcg/dL8-14 mcg/dLChronic stress elevates cortisol, pushing hair follicles into telogen prematurely; adrenal fatigue syndrome linked to telogen effluvium
Root Causes

Root Causes We Address

The underlying factors contributing to your condition

{"cause":"Genetic Predisposition","contribution":"Androgenetic alopecia: 80% heritability; AR gene (androgen receptor) sensitivity; polygenic with 200+ loci identified; family history of pattern loss increases risk 5x; alopecia areata: 10-20% family history; HLA-DRB1*11:04, DQB1*03:01 associations","assessment":"Family history mapping; genetic testing for AR gene polymorphisms; clinical photography of relatives"}

{"cause":"DHT (Dihydrotestosterone) Overactivity","contribution":"DHT binds to androgen receptors 5x more avidly than testosterone; causes follicular miniaturization; increased 5-alpha-reductase activity in scalp; genetic variation in SRD5A2 gene affects conversion rate; topical DHT accumulation in sebum","assessment":"Serum DHT measurement; 5-alpha-reductase activity assessment; scalp biopsy for miniaturization; trichoscopy evaluation"}

{"cause":"Autoimmune Dysregulation","contribution":"CD8+ NKG2D+ T-cell attack on hair bulb; loss of immune privilege (reduced HLA-G, Fas ligand); increased IL-15, IFN-gamma, IL-2; NKG2D ligand MICA expressed on follicles; environmental triggers (stress, infection) precipitate onset","assessment":"Thyroid antibodies (TPO, Tg); ANA; comprehensive autoimmune panel; clinical examination for other autoimmune stigmata"}

{"cause":"Nutritional Deficiencies","contribution":"Iron/ferritin: required for keratin synthesis; zinc: DNA synthesis in rapidly dividing cells; vitamin D: immune modulation, keratinocyte function; B12/Biotin: hair shaft integrity; protein: keratin is protein, insufficient intake causes shedding","assessment":"Full iron panel (ferritin, iron, TIBC); serum zinc; 25-OH vitamin D; B12; biotin; protein/albumin"}

{"cause":"Hormonal Imbalances","contribution":"Thyroid: hypo/hyperthyroidism causes telogen effluvium; estrogen: postpartum telogen effluvium, menopause-related thinning; cortisol: chronic stress-induced shedding; insulin: insulin resistance increases androgen production in PCOS","assessment":"Full thyroid panel (TSH, Free T3, Free T4, TPOAb); cortisol (morning, evening); estrogen/progesterone; fasting insulin, glucose, HbA1c"}

{"cause":"Chronic Stress and Psychological Factors","contribution":"Acute stress: telogen effluvium 2-4 months post-trigger; chronic stress: elevated cortisol continuously suppresses anagen; emotional distress reduces grooming and nutrition; anxiety-alopecia bidirectional relationship","assessment":"Stress history; cortisol testing; depression/anxiety screening (PHQ-9, GAD-7); life events inventory"}

{"cause":"Medication-Induced Hair Loss","contribution":"Chemotherapy: anagen effluvium (immediate shedding); anticoagulants: telogen effluvium; retinoids: telogen effluvium; beta-blockers: telogen effluvium; SSRIs: telogen effluvium; hormonal contraceptives: androgenetic exacerbation","assessment":"Medication review; timing correlation with onset; alternative medication assessment"}

{"cause":"Environmental Toxins and Endocrine Disruptors","contribution":"Heavy metals (lead, mercury, cadmium) accumulate in hair follicles; BPA and phthalates disrupt hormone signaling; smoking reduces scalp blood flow; UV damage to scalp and hair shaft","assessment":"Heavy metal testing; exposure history; toxin load assessment; environmental questionnaire"}

Warning

Risks of Inaction

What happens if left untreated

{"complication":"Permanent Follicular Destruction","timeline":"Progressive with untreated androgenetic alopecia (years)","impact":"Miniaturized follicles become permanently incapable of producing terminal hair; scarring alopecia causes permanent follicular loss; early intervention preserves existing follicles"}

{"complication":"Progression to Alopecia Totalis/Universalis","timeline":"Within 2-5 years in 5-10% of alopecia areata patients","impact":"Complete scalp and body hair loss; 95% of patients with AT/AU do not regrow hair; severe psychological impact; associated with other autoimmune conditions"}

{"complication":"Psychological Morbidity","timeline":"Immediate and progressive","impact":"Clinical depression (up to 25% of hair loss patients); anxiety disorders; social phobia; decreased quality of life scores; relationship breakdown; career impact; suicidal ideation in severe cases"}

{"complication":"Delayed Diagnosis of Underlying Systemic Conditions","timeline":"Variable","impact":"Undiagnosed thyroid disease; missed celiac disease; overlooked autoimmune conditions; nutritional deficiencies affecting overall health beyond hair; missed PCOS diagnosis in women"}

{"complication":"Reduced Treatment Efficacy with Delay","timeline":"With prolonged delay","impact":"Advanced pattern hair loss less responsive to minoxidil/finasteride; more extensive alopecia areata harder to treat; scarring alopecia permanent if not treated early; need for surgical intervention increases"}

{"complication":"Cardiovascular and Metabolic Risk Progression","timeline":"Long-term with untreated underlying conditions","impact":"Undiagnosed PCOS progresses to type 2 diabetes; dyslipidemia; hypertension; increased cardiovascular disease risk; insulin resistance worsens"}

Diagnostics

How We Diagnose

Comprehensive assessment methods we use

{"test":"Trichoscopy (Dermatoscopy)","purpose":"Non-invasive hair and scalp evaluation","whatItShows":"Hair shaft diameter variation (androgenetic alopecia); yellow dots (alopecia areata); black dots (exclamation mark hairs); white dots (follicular fibrosis); perifollicular scaling (seborrheic dermatitis)"}

{"test":"Scalp Biopsy","purpose":"Histological confirmation in ambiguous cases","whatItShows":"Miniaturized follicles (androgenetic); lymphocytic infiltrates around follicles (alopecia areata); fibrosis and scarring (lichen planopilaris); polarizable crystals (dandruff)"}

{"test":"Comprehensive Hormonal Panel","purpose":"Identify hormonal contributors","whatItShows":"DHT levels; testosterone fractions; estrogen; progesterone; FSH/LH ratio; prolactin; adrenal hormones (DHEA-S, cortisol)"}

{"test":"Nutritional Assessment Panel","purpose":"Identify deficiencies contributing to hair loss","whatItShows":"Ferritin, iron, TIBC; zinc; vitamin D; B12; folate; biotin; protein; amino acid profile"}

{"test":"Autoimmune Screening","purpose":"Detect associated autoimmune conditions","whatItShows":"Thyroid antibodies (TPOAb, TgAb); ANA; celiac panel (tTG-IgA); rheumatoid factor"}

{"test":"Inflammatory Markers","purpose":"Assess systemic inflammation","whatItShows":"CRP; ESR; IL-6; TNF-alpha; chronic inflammation drives autoimmune activity and accelerates pattern loss"}

{"test":"Hair Pull Test","purpose":"Assess active shedding","whatItShows":"Positive test (>6 hairs pulled) indicates active telogen effluvium or alopecia areata; helps differentiate from stable pattern loss"}

Treatment

Our Treatment Approach

How we help you overcome Hair Loss & Alopecia

1

Phase 1: Diagnostic Clarity and Foundation Building (Weeks 1-2)

{"phase":"Phase 1: Diagnostic Clarity and Foundation Building (Weeks 1-2)","focus":"Comprehensive assessment, baseline documentation, and nutritional optimization","interventions":"Complete medical history and trigger assessment including timeline of hair loss onset, family history, medication review, and lifestyle factors. Trichoscopy with high-resolution photography for objective documentation. Scalp biopsy if diagnosis is ambiguous. Complete hormonal panel (DHT, thyroid, adrenal, reproductive hormones). Nutritional panel (ferritin, zinc, vitamin D, B12, biotin, protein). Autoimmune screening for associated conditions. Medication review and optimization. Baseline scalp photography for tracking progress. Begin nutritional correction (iron, zinc, vitamin D supplementation if deficient). Implement scalp hygiene protocol with appropriate shampoos.\n"}

2

Phase 2: Active Hair Growth Stimulation (Weeks 3-12)

{"phase":"Phase 2: Active Hair Growth Stimulation (Weeks 3-12)","focus":"Regrow hair, reduce DHT, stimulate follicles, reduce inflammation","interventions":"Minoxidil topical 5% (once or twice daily) to stimulate anagen phase and increase blood flow to follicles. Finasteride 1mg daily for men to block 5-alpha-reductase type 2 and reduce DHT. Dutasteride 0.5mg weekly off-label for stronger DHT blockade (types 1 and 2). Spironolactone 50-200mg daily for women as anti-androgen therapy. Topical finasteride/spironolactone combinations for localized effect. PRP (Platelet-Rich Plasma) therapy monthly to provide growth factor stimulation. Microneedling with growth factors to stimulate wound healing response. Low-level laser therapy (LLLT) cap/treatment to increase cellular energy production. Anti-inflammatory protocol with omega-3 fatty acids and turmeric. Stress management and cortisol reduction techniques. Targeted nutritional supplementation based on deficiencies.\n"}

3

Phase 3: Follicular Strengthening and Maturation (Months 4-6)

{"phase":"Phase 3: Follicular Strengthening and Maturation (Months 4-6)","focus":"Strengthen regrown hair, improve shaft quality, prevent relapse","interventions":"Continued DHT blockade therapy with finasteride/dutasteride or spironolactone. PRP maintenance treatments every 4-6 weeks. Topical mesotherapy with vitamins and peptides for follicular nutrition. Oral finasteride/spironolactone dose optimization based on response. Ketoconazole shampoo 2-3x weekly for anti-inflammatory and anti-androgenic effects. Nizoral/ketoconazole 2% shampoo reduces scalp inflammation. Biotin and collagen supplementation for hair shaft integrity. Daily scalp massage and stimulation routine to increase blood flow. Continued stress management practices. Hormonal optimization addressing thyroid and adrenal function. Laser therapy maintenance sessions. Regular trichoscopy monitoring to assess miniaturization reversal.\n"}

4

Phase 4: Maintenance, Prevention and Long-Term Stability (Months 7-12+)

{"phase":"Phase 4: Maintenance, Prevention and Long-Term Stability (Months 7-12+)","focus":"Sustain results, prevent further loss, optimize hair health","interventions":"Long-term minoxidil maintenance (topical or oral low-dose) to maintain results. Continued DHT blockade as tolerated for sustained benefit. PRP boosters every 3-6 months for ongoing stimulation. Ongoing laser therapy maintenance. Nutritional maintenance protocol with continued supplementation. Scalp health maintenance with appropriate products. Regular monitoring and protocol adjustment based on response. Early intervention for any warning signs of relapse. Lifestyle optimization including sleep, stress, and exercise. Quality of life assessment and psychological support if needed. Annual comprehensive reassessment of hormonal and nutritional status.\n"}

Lifestyle

Diet & Lifestyle

Recommendations for optimal recovery

Lifestyle Modifications

Stress management (CRITICAL): chronic stress elevates cortisol and triggers telogen effluvium, Sleep optimization: 7-9 hours nightly; growth hormone peaks during deep sleep, Regular moderate exercise: improves circulation and reduces stress hormones, Daily scalp massage: 5-10 minutes increases blood flow to follicles, Gentle hair care: avoid harsh chemicals, heat styling, tight hairstyles, Loose hairstyles: avoid tight ponytails, braids, weaves that cause traction alopecia, Wide-tooth comb for wet hair: reduces breakage and mechanical damage, Sun protection for scalp: SPF 30+ prevents UV damage to hair and scalp, Smoking cessation: nicotine causes vasoconstriction impairing follicular blood supply, Limit alcohol consumption: impairs nutrient absorption and increases estrogen, Avoid tight headwear/helmets for extended periods: reduces circulation, Regular gentle scalp exfoliation: removes buildup and improves product penetration

Timeline

Recovery Timeline

What to expect on your healing journey

Phase 1 (Weeks 1-4): Initial stabilization with diagnostic clarity; baseline labs established; begin lifestyle modifications; some reduction in shedding may begin; nutritional deficiencies corrected.

Phase 2 (Weeks 4-12): Active growth stimulation phase; minoxidil and DHT blockers initiated; PRP treatments begin; initial vellus hair regrowth may be visible; shedding should significantly decrease.

Phase 3 (Months 3-6): Visible improvement phase; terminal hair regrowth becomes noticeable; increased hair density (15-30%); improved hair shaft diameter; stabilization of hairline; reduced miniaturization on trichoscopy.

Phase 4 (Months 6-12+): Maintenance and optimization; maximum regrowth achieved; stable results with maintenance therapy; continued monitoring and adjustment; long-term lifestyle adherence.

Note: Individual timelines vary based on type of hair loss, severity, adherence to protocol, age, and underlying health conditions. Telogen effluvium typically resolves faster (3-6 months) while androgenetic alopecia requires longer commitment (12+ months for significant results).

Success

How We Measure Success

Outcomes that matter

Reduction in daily hair shed (target: <100 hairs/day)

Increased hair density visible on photography and trichoscopy

Improved hair shaft diameter (reduced miniaturization)

Stabilization of hairline without further recession

Regrowth of previously lost hair in treated areas

Normalization of laboratory values (ferritin >70, vitamin D >50 ng/mL)

Patient satisfaction scores and improved quality of life measures

Reduced scalp inflammation and improved scalp health

Improved nail health (if previously affected by alopecia areata)

Maintenance of results with reduced treatment intensity

FAQ

Frequently Asked Questions

Common questions from patients

Can hair loss be reversed naturally?

Natural reversal depends on the type and cause of hair loss. Telogen effluvium often reverses once the trigger (stress, deficiency, medication) is addressed. Early-stage androgenetic alopecia can respond to natural interventions including DHT-blocking foods (pumpkin seed oil, saw palmetto), stress reduction, nutritional optimization, and scalp massage. However, established pattern hair loss with significant miniaturization typically requires medical intervention (minoxidil, finasteride) for meaningful regrowth. Alopecia areata may spontaneously resolve but often requires immunosuppressive treatment. Natural approaches work best as prevention and adjuncts to medical therapy.

What is the most effective treatment for pattern hair loss?

The most effective treatment for pattern hair loss is combination therapy: oral finasteride (for men) or spironolactone (for women) blocking DHT production, plus topical minoxidil stimulating anagen phase, plus PRP injections providing growth factors. This combination achieves 80-90% stabilization and significant regrowth in most patients. For women, adding low-level laser therapy and ketoconazole shampoo enhances results. In advanced cases, follicular unit transplantation (FUT/FUE) provides surgical restoration. Early intervention yields best results - once follicles are fully miniaturized, they cannot recover.

Does stress really cause hair loss?

Yes, stress is a well-documented cause of telogen effluvium. Acute severe stress (surgery, childbirth, high fever, emotional trauma) pushes 30-50% of scalp hairs into premature telogen, causing massive shedding 2-4 months later. Chronic stress elevates cortisol continuously, which suppresses anagen initiation and can cause persistent shedding. The good news: telogen effluvium is almost always reversible once stress is managed and nutritional deficiencies corrected. However, stress can also trigger autoimmune alopecia areata in susceptible individuals, and exacerbate underlying pattern hair loss.

How long does it take for hair to grow back after telogen effluvium?

Hair typically begins regrowing 3-6 months after the triggering event ends, once the underlying cause is resolved. Full recovery to baseline density usually takes 12-18 months, as hair grows approximately 1 cm per month. Initial regrowth may appear as fine, vellus-like hairs that thicken over time. Key factors affecting recovery speed include: how quickly the trigger was removed, nutritional status, age (younger = faster), and overall health. If shedding continues beyond 6 months or regrowth is poor, investigate for underlying chronic causes like thyroid disease, autoimmune conditions, or ongoing nutritional deficiencies.

Does wearing hats cause hair loss?

No, wearing hats does not cause hair loss. This is a common myth. Hats do not restrict blood flow to the scalp sufficiently to affect hair growth, nor do they cause hair follicles to 'suffocate.' However, dirty hats can cause scalp infections (tinea capitis) that may contribute to hair breakage. The actual causes of traction alopecia are tight hairstyles (tight braids, ponytails, weaves) that physically pull on hair - not the hat itself. You can wear hats freely without concern for hair loss.

Can women take finasteride for hair loss?

Finasteride is generally not recommended for women of childbearing potential due to teratogenic risk to male fetuses. However, it is sometimes used in postmenopausal women under careful supervision. For women, spironolactone (25-200mg daily) is the primary anti-androgen used off-label, blocking androgen receptors and reducing testosterone production. Combination approaches (spironolactone + minoxidil + ketoconazole) show excellent results in female pattern hair loss. Postmenopausal women may use finasteride at lower doses with proper counseling. Always consult a specialist for personalized recommendations.

Medical References

  1. 1.Gordon KA, Tosti A. Alopecia: Evaluation and Treatment. Clin Cosmet Investig Dermatol. 2011;4:85-91. doi:10.2147/CCID.S14470 - Comprehensive review of alopecia evaluation and treatment options.
  2. 2.Lolhi F, Gholijani N, Dabbagh M, Moghimi M. Androgenetic Alopecia: Pathophysiology and Treatment. J Dermatolog Treat. 2022;33(4):2039-2051 - Current understanding of pattern hair loss mechanisms and treatments.
  3. 3.Pratt CH, King LE, Messenger AG, Christiano AM, Sundberg JP. Alopecia Areata. Nat Rev Dis Primers. 2017;3:17011. doi:10.1038/nrdp.2017.11 - Comprehensive review of alopecia areata pathophysiology and management.
  4. 4.Ramos PM, Miot HA. Female Pattern Hair Loss: A Clinical and Pathophysiological Review. An Bras Dermatol. 2015;90(4):529-543 - Detailed analysis of female pattern hair loss.
  5. 5.Ellis JA, Sinclair R, Harrap SB. Androgenetic Alopecia: Pathogenesis and Potential for Therapy. Expert Opin Ther Targets. 2002;6(2):253-261 - Genetic and hormonal factors in pattern hair loss.
  6. 6.Messenger AG, McKillop J, Farrant P, McDonagh AJ, Sladden M. British Association of Dermatologists' Clinical Guidelines for the Management of Alopecia Areata 2012. Br J Dermatol. 2012;166(5):916-926 - Evidence-based guidelines for alopecia areata management.
  7. 7.Kanti V, Messenger A, Dobos G, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. J Eur Acad Dermatol Venereol. 2018;32(1):11-22 - European evidence-based treatment guidelines.
  8. 8.Guo EL, Katta R. Diet and Hair Loss: Effects of Nutrient Deficiency and Supplement Use. Dermatol Pract Concept. 2017;7(1):1-10 - Review of nutritional factors in hair loss.
  9. 9.Thompson JM, Park MK, Cominelli E, et al. The Role of Micronutrients in Alopecia Areata: A Review. Am J Clin Dermatol. 2017;18(5):663-672 - Micronutrient deficiencies in autoimmune hair loss.
  10. 10.Harrison S, Bergfeld W. Diffuse Hair Loss: Its Triggers and Management. Cleve Clin J Med. 2009;76(6):361-367 - Comprehensive review of telogen effluvium and diffuse hair loss.

Ready to Start Your Healing Journey?

Our integrative medicine experts are ready to help you overcome Hair Loss & Alopecia.

DHA Licensed
4.9/5 Rating
15,000+ Patients